CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31) of $712.00 thousand for the 12-month period ending 2012-12-29, per its 10-K filed 2013-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax · last filed 2013-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for the quarter ending 2012-12-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for the quarter ending 2012-09-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $712.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for fiscal 2012 was $712.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for fiscal 2011 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2012-01-31) for fiscal 2010 was $0.00.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | $712.00K 10-K · filed 2013-02-27 |
| 2012-09-29 | $0.00 10-Q · filed 2012-11-01 | $0.00 derived: sum of 2 quarters · filed 2012-11-01 | $712.00K 10-Q · filed 2012-11-01 | $712.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-07 | $712.00K 10-Q · filed 2012-08-07 | $712.00K derived: sum of 3 quarters · filed 2013-02-27 | $712.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-03-31 | $712.00K 10-Q · filed 2012-05-04 | $712.00K derived: sum of 2 quarters · filed 2013-02-27 | $712.00K derived: sum of 3 quarters · filed 2013-02-27 | $712.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | $0.00 10-K · filed 2013-02-27 |
| 2011-09-24 | $0.00 10-Q · filed 2012-11-01 | $0.00 derived: sum of 2 quarters · filed 2012-11-01 | $0.00 10-Q · filed 2012-11-01 | |
| 2011-06-25 | $0.00 10-Q · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | ||
| 2011-03-26 | $0.00 10-Q · filed 2012-05-04 | |||
| 2010-12-25 | $0.00 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |